Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Niedelman’s successors

This article was originally published in The Tan Sheet

Executive Summary

FDA's Office of Regulatory Affairs will have two deputy associate commissioners for regulatory affairs following the departure Steven Niedelman, the agency announces June 22. Niedelman recently said he will leave ORA at the end of June to join Quintiles Consulting as executive vice president (1"The Tan Sheet", June 19, In Brief). Diana Kolaitis will serve as a deputy ACRA, taking the lead responsibility for the operational aspects of ORA's work, including the achievement of inspections and lab work. The second deputy post will be filled by David Horowitz, who will lead strategic operations by setting priorities, developing policies, and finding new methods with which to fill ORA's mission...

You may also be interested in...



Niedelman retires

Deputy Associate Commissioner for Regulatory Operations Steven Niedelman will retire from the agency at the end of the month, according to a June 15 announcement. He will join Quintiles Consulting as an executive vice president, FDA states...

The Good, The Bad And The Ugly Of COVID-19 Vaccine Manufacturing Technology Platforms

Not all technology platforms provide the expected benefit of filling in CMC review gaps and speeding coronavirus vaccine approvals.

SparingVision Raises €44.5m For Mutation-Agnostic Eye Gene Therapy

A long-term, patient-centric group of investors is backing SparingVision's bid to develop a gene therapy treatment for retinitis pigmentosa that could be effective regardless of mutation.

Topics

UsernamePublicRestriction

Register

GB150348

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel